Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / SHS NEW
-
Total 13F shares
-
1,270,878
-
Share change
-
+38,830
-
Total reported value
-
$4,575,161
-
Price per share
-
$3.60
-
Number of holders
-
12
-
Value change
-
+$113,597
-
Number of buys
-
5
-
Number of sells
-
4
Institutional Holders of CollPlant Biotechnologies Ltd - SHS NEW (CLGN) as of Q4 2024
As of 31 Dec 2024,
CollPlant Biotechnologies Ltd - SHS NEW (CLGN) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,270,878 shares.
The largest 10 holders included
PINNACLE ASSOCIATES LTD, VILLERE ST DENIS J & CO LLC, BROWN ADVISORY INC, AMH Equity Ltd, UBS Group AG, Pathstone Holdings, LLC, RENAISSANCE TECHNOLOGIES LLC, WELLS FARGO & COMPANY/MN, BANK OF AMERICA CORP /DE/, and NATIONAL BANK OF CANADA /FI/.
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.